Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinchen Qingjin Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital, specifically within the clinical tradition of Dr. Xi Jiuyi. It is primarily indicated for the treatment of diabetic foot gangrene, particularly the 'tendon gangrene' (Jinju) subtype characterized by damp-heat syndrome. The decoction is designed to clear heat, resolve dampness, and detoxify the tendons and soft tissues. Its therapeutic effects involve the regulation of inflammatory mediators, such as reducing pro-inflammatory cytokines (TNF-alpha, IL-6), and the promotion of local microcirculation and angiogenesis (via VEGF pathways) to facilitate the healing of chronic ulcers and prevent further tissue necrosis. It is typically used as an oral intervention in an integrated medical setting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinchen Qingjin Decoction.